Reversal of Severe Diuretic Resistance by Dexmedetomidine Associated Polyuria in Type 1 Cardiorenal Syndrome: A Case Report

Clicks: 3
ID: 338023
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #406 of 408 articles by views in European Heart Journal - Case Reports

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 408 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Dexmedetomidine is a selective α2-adrenergic agonist widely used for sedation in intensive care settings. Although hypotension and bradycardia are well-recognized adverse effects, dexmedetomidine-associated polyuria is a rare and unpredictable adverse effect. Case Summary An 84-year-old man with ischemic dilated cardiomyopathy, permanent atrial fibrillation, type 2 diabetes mellitus, and chronic kidney disease was admitted to the Cardiac Intensive Care Unit with type 1 cardiorenal syndrome, severe systemic and pulmonary congestion, oliguria and acute kidney injury. Despite continuous intravenous furosemide infusion, sequential nephron blockade, and dual vasoactive support with norepinephrine and dobutamine, the patient developed persistent oligo-anuria and worsening congestion. Dexmedetomidine infusion was initiated for psychomotor agitation and disorientation. Shortly thereafter, urine output abruptly increased to approximately 250 mL/h, accompanied by rapid decongestion and improvement in renal function. Following dexmedetomidine withdrawal, oliguria, congestion and renal dysfunction recurred. Rechallenge with dexmedetomidine again induced profound polyuria, with urine output peaking at 650 mL/h and a 10-kg weight loss over 48 hours, allowing de-escalation of diuretic therapy and withdrawal of vasoactive support. The Naranjo score was 6, supporting a probable causal relationship. Discussion This case demonstrates a reproducible temporal association between dexmedetomidine administration and profound polyuria, confirmed by positive rechallenge.
Reference Key
openalex_W7224757056 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Giulio Barazzetta, Stefano Vicini, Francesca Bruni, Francesca Bodega, Stefano Maggiolini
Are you one of these authors? Claim your profile
Journal European Heart Journal - Case Reports
Year 2026
DOI
10.1093/ehjcr/ytag787
URL
https://academic.oup.com/ehjcr/advance-article-pdf/doi/10.1093/ehjcr/ytag787/72614312/ytag787.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.